Entrada Therapeutics, Inc. (TRDA) by event type
TRDA moves most on analyst downgrades — a median of -0.68% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the TRDA overview →
How TRDA reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 2,320 of 2,603 | 10 | -0.68% | 30% | -0.66% |
| Coverage initiations 1,104 of 2,283 | 14 | 0.00% | 43% | +3.77% |
| Rating reiterations 2,514 of 3,522 | 29 | -0.09% | 38% | +0.27% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how TRDA usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · TRDA overview →